The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Joosten, L. A. B.
Right arrow Articles by van den Berg, W. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Joosten, L. A. B.
Right arrow Articles by van den Berg, W. B.
The Journal of Immunology, 2003, 171: 6145-6153.
Copyright © 2003 by The American Association of Immunologists

Toll-Like Receptor 2 Pathway Drives Streptococcal Cell Wall-Induced Joint Inflammation: Critical Role of Myeloid Differentiation Factor 88

Leo A. B. Joosten1,*, Marije I. Koenders*, Ruben L. Smeets*, Marleen Heuvelmans-Jacobs*, Monique M. A. Helsen*, Kiyoshi Takeda{dagger}, Shizuo Akira{dagger}, Erik Lubberts*, Fons A. J. van de Loo* and Wim B. van den Berg*

* Rheumatology Research Laboratory and Advanced Therapeutics, University Medical Center Nijmegen, Nijmegen, The Netherlands; and {dagger} Department of Host Defense, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan

The IL-1R/Toll-like receptor (TLR) superfamily of receptors has a key role in innate immunity and inflammation. In this study, we report that streptococcal cell wall (SCW)-induced joint inflammation is predominantly dependent on TLR-2 signaling, since TLR-2-deficient mice were unable to develop either joint swelling or inhibition of cartilage matrix synthesis. Myeloid differentiation factor 88 (MyD88) is a Toll/IL-1R domain containing adaptor molecule known to have a central role in both IL-1R/IL-18R and TLR signaling. Mice deficient for MyD88 did not develop SCW-induced arthritis; both joint swelling and disturbance of cartilage chondrocyte anabolic function was completely abolished. Local levels of proinflammatory cytokines and chemokines in synovial tissue washouts were strongly reduced in MyD88-deficient mice. Histology confirmed the pivotal role of MyD88 in acute joint inflammation. TLR-2-deficient mice still allow influx of inflammatory cells into the joint cavity, although the number of cells was markedly reduced. No influx of inflammatory cells was seen in joints of MyD88-deficient mice. In addition, cartilage matrix proteoglycan loss was completely absent in MyD88 knockout mice. These findings clearly demonstrated that MyD88 is a key component in SCW-induced joint inflammation. Since agonists of the Toll-like pathway are abundantly involved in both septic and rheumatoid arthritis, targeting of MyD88 may be a novel therapy in inflammatory joint diseases.




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
L. A. B. Joosten, B. Heinhuis, S. Abdollahi-Roodsaz, G. Ferwerda, L. LeBourhis, D. J. Philpott, M.-A. Nahori, C. Popa, S. A. Morre, J. W. M. van der Meer, et al.
Differential function of the NACHT-LRR (NLR) members Nod1 and Nod2 in arthritis
PNAS, July 1, 2008; 105(26): 9017 - 9022.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
T. G. Loof, O. Goldmann, and E. Medina
Immune Recognition of Streptococcus pyogenes by Dendritic Cells
Infect. Immun., June 1, 2008; 76(6): 2785 - 2792.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
M. Loiarro, F. Capolunghi, N. Fanto, G. Gallo, S. Campo, B. Arseni, R. Carsetti, P. Carminati, R. De Santis, V. Ruggiero, et al.
Pivotal Advance: Inhibition of MyD88 dimerization and recruitment of IRAK1 and IRAK4 by a novel peptidomimetic compound
J. Leukoc. Biol., October 1, 2007; 82(4): 801 - 810.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
K. Salojin and T. Oravecz
Regulation of innate immunity by MAPK dual-specificity phosphatases: knockout models reveal new tricks of old genes
J. Leukoc. Biol., April 1, 2007; 81(4): 860 - 869.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
C Plater-Zyberk, L A B Joosten, M M A Helsen, J Hepp, P A Baeuerle, and W B van den Berg
GM-CSF neutralisation suppresses inflammation and protects cartilage in acute streptococcal cell wall arthritis of mice
Ann Rheum Dis, April 1, 2007; 66(4): 452 - 457.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. M. Sacre, E. Andreakos, S. Kiriakidis, P. Amjadi, A. Lundberg, G. Giddins, M. Feldmann, F. Brennan, and B. M. Foxwell
The Toll-Like Receptor Adaptor Proteins MyD88 and Mal/TIRAP Contribute to the Inflammatory and Destructive Processes in a Human Model of Rheumatoid Arthritis
Am. J. Pathol., February 1, 2007; 170(2): 518 - 525.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
Y. JUARRANZ, I. GUTIERREZ-CANAS, A. ARRANZ, C. MARTINEZ, C. ABAD, J. LECETA, J.L. PABLOS, and R.P. GOMARIZ
VIP Decreases TLR4 Expression Induced by LPS and TNF-{alpha} Treatment in Human Synovial Fibroblasts
Ann. N.Y. Acad. Sci., July 1, 2006; 1070(1): 359 - 364.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. F. Roelofs, W. C. Boelens, L. A. B. Joosten, S. Abdollahi-Roodsaz, J. Geurts, L. U. Wunderink, B. W. Schreurs, W. B. van den Berg, and T. R. D. J. Radstake
Identification of Small Heat Shock Protein B8 (HSP22) as a Novel TLR4 Ligand and Potential Involvement in the Pathogenesis of Rheumatoid Arthritis.
J. Immunol., June 1, 2006; 176(11): 7021 - 7027.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. I. Koenders, E. Lubberts, F. A. J. van de Loo, B. Oppers-Walgreen, L. van den Bersselaar, M. M. Helsen, J. K. Kolls, F. E. Di Padova, L. A. B. Joosten, and W. B. van den Berg
Interleukin-17 Acts Independently of TNF-{alpha} under Arthritic Conditions
J. Immunol., May 15, 2006; 176(10): 6262 - 6269.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
I. Gutierrez-Canas, Y. Juarranz, B. Santiago, A. Arranz, C. Martinez, M. Galindo, M. Paya, R. P. Gomariz, and J. L. Pablos
VIP down-regulates TLR4 expression and TLR4-mediated chemokine production in human rheumatoid synovial fibroblasts
Rheumatology, May 1, 2006; 45(5): 527 - 532.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
A. K. Behera, E. Hildebrand, R. T. Bronson, G. Perides, S. Uematsu, S. Akira, and L. T. Hu
MyD88 Deficiency Results in Tissue-Specific Changes in Cytokine Induction and Inflammation in Interleukin-18-Independent Mice Infected with Borrelia burgdorferi
Infect. Immun., March 1, 2006; 74(3): 1462 - 1470.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. A. B. Joosten, M. G. Netea, S.-H. Kim, D.-Y. Yoon, B. Oppers-Walgreen, T. R. D. Radstake, P. Barrera, F. A. J. van de Loo, C. A. Dinarello, and W. B. van den Berg
IL-32, a proinflammatory cytokine in rheumatoid arthritis
PNAS, February 28, 2006; 103(9): 3298 - 3303.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. V. Salojin, I. B. Owusu, K. A. Millerchip, M. Potter, K. A. Platt, and T. Oravecz
Essential Role of MAPK Phosphatase-1 in the Negative Control of Innate Immune Responses
J. Immunol., February 1, 2006; 176(3): 1899 - 1907.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
M. G. Netea, J. W. M. Van der Meer, R. P. Sutmuller, G. J. Adema, and B.-J. Kullberg
From the Th1/Th2 Paradigm towards a Toll-Like Receptor/T-Helper Bias
Antimicrob. Agents Chemother., October 1, 2005; 49(10): 3991 - 3996.
[Full Text] [PDF]


Home page
J. Immunol.Home page
E. Lubberts, P. Schwarzenberger, W. Huang, J. R. Schurr, J. J. Peschon, W. B. van den Berg, and J. K. Kolls
Requirement of IL-17 Receptor Signaling in Radiation-Resistant Cells in the Joint for Full Progression of Destructive Synovitis
J. Immunol., September 1, 2005; 175(5): 3360 - 3368.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Loiarro, C. Sette, G. Gallo, A. Ciacci, N. Fanto, D. Mastroianni, P. Carminati, and V. Ruggiero
Peptide-mediated Interference of TIR Domain Dimerization in MyD88 Inhibits Interleukin-1-dependent Activation of NF-{kappa}B
J. Biol. Chem., April 22, 2005; 280(16): 15809 - 15814.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
E.-K. Lee, S.-M. Kang, D.-J. Paik, J. M. Kim, and J. Youn
Essential roles of Toll-like receptor-4 signaling in arthritis induced by type II collagen antibody and LPS
Int. Immunol., March 1, 2005; 17(3): 325 - 333.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
L. A.B. Joosten, R. L. Smeets, M. I. Koenders, L. A.M. van den Bersselaar, M. M.A. Helsen, B. Oppers-Walgreen, E. Lubberts, Y. Iwakura, F. A.J. van de Loo, and W. B. van den Berg
Interleukin-18 Promotes Joint Inflammation and Induces Interleukin-1-Driven Cartilage Destruction
Am. J. Pathol., September 1, 2004; 165(3): 959 - 967.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. D. Bolz, R. S. Sundsbak, Y. Ma, S. Akira, C. J. Kirschning, J. F. Zachary, J. H. Weis, and J. J. Weis
MyD88 Plays a Unique Role in Host Defense but Not Arthritis Development in Lyme Disease
J. Immunol., August 1, 2004; 173(3): 2003 - 2010.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. P. Leung, D. Xu, S. Culshaw, I. B. McInnes, and F. Y. Liew
A Novel Therapy of Murine Collagen-Induced Arthritis with Soluble T1/ST2
J. Immunol., July 1, 2004; 173(1): 145 - 150.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.